Purpose: To quantitatively analyze and compare the fundoscopic features between fellow eyes of retinal angiomatous proliferation and typical exudative age-related macular degeneration and to identify possible predictors of neovascularization.
B
ased on the first description by Hartnett et al 1 in 1992, Yannuzzi et al 2 introduced the term retinal angiomatous proliferation (RAP) to describe a distinct phenotype of exudative age-related macular degeneration (eAMD), in which the neovascular complex originates deeply in the retina. 3, 4 Retinal angiomatous proliferation has also been labeled Type 3 neovascularization and the two terms have been used interchangeably. 5, 6 Although the prevalence of the disease is low in asians 7, 8 and blacks, 5 RAP is estimated to represent 12% to 20% of the wet age-related macular degeneration (AMD) cases in white populations, 2, 6, [9] [10] [11] where it poses a substantial burden.
It is currently well established that RAP and typical eAMD present distinct clinical and epidemiologic features (age, sex, among others 12, 13 ), most of them likely due to genetic differences still not completely understood. 14 Retinal angiomatous proliferation has been coined a bilaterally aggressive disease with predictable symmetry. 5 Although definite proof on the form of From the *Department of Ophthalmology, Centro Hospitalar e Universitário de Coimbra (CHUC), Coimbra, Portugal; †Association for Innovation and Biomedical Research on Light and Image (AIBILI), Coimbra, Portugal; and ‡Faculty of Medicine, University of Coimbra (FMUC), Coimbra, Portugal.
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Reprint requests: João Pedro Marques, MD, MSc, Department of Ophthalmology, Centro Hospitalar e Universitário de Coimbra, Praceta Prof. Mota Pinto, 3049 Coimbra, Portugal; e-mail: marquesjoaopedro@ gmail.com a prospective randomized clinical trial is still lacking, the vasogenic potential associated with RAP has been highlighted by several study groups, 9, 15, 16 reporting annual and cumulative rates of neovascularization in fellow eyes far exceeding the typical forms of eAMD. Considering this alleged aggressiveness, the identification of pre-exudative changes in the fellow eye, potentially associated with a higher risk of neovascularization, is of the utmost importance.
Fundoscopic features such as drusen characteristics or the presence of pigmentary changes are considered important ocular risk factors for typical eAMD. [17] [18] [19] [20] [21] Because of its relevance in clinical practice, the AREDS group 22 created a simplified point scoring system that provides baseline risk stratification, allows tracking of progression, and defines surrogate outcomes for progression by estimating the 5-year risk of developing advanced AMD. Despite the well-documented presence of soft drusen and pigmentary changes in eyes with RAP, 2, 4, 16, [23] [24] [25] [26] [27] an objective and rigorous analysis of their characteristics and an assessment of their possible influence in the development of neovascularization in the fellow eye is lacking. The characterization of phenotypic risk factors in fellow eyes of RAP could be of practical clinical value, since it would alert the eye-care providers for the possibility of a more aggressive scenario. The purpose of this study was to assess and compare the fundoscopic changes in fellow eyes of RAP and typical eAMD and to identify possible predictors of neovascularization.
Methods
Retrospective case-control study. Enrolled patients were consecutively selected from a database initially created as part of a prospective observational study (Characterization of Early Markers of Choroidal Neovascularization -CNV Markers, 28 NCT00801541) designed to identify morphological and/or functional predictors of neovascularization in unaffected fellow eyes of exudative AMD. At enrollment, every included subject was asked to sign an informed consent form in accordance with the Declaration of Helsinki, where they agreed that their clinical data could be included in scientific studies. Bilateral color fundus digital photographs (CFP), spectral domain optical coherence tomography, fluorescein angiography, and indocyanine green angiography were performed at baseline in every patient, along with a complete ophthalmological examination. During follow-up, all patients had periodical visits, where the ophthalmological examination and optical coherence tomography were always repeated. If the study eye (fellow eye) developed neovascularization, its incidence, time of occurrence, and phenotype were registered. All the diagnoses were confirmed by two of three senior retina specialists (R.S., M.d.L.C., or J.F.), after reviewing the ocular changes using multimodal retinal imaging (CFP, spectral domain optical coherence tomography, fluorescein angiography, and indocyanine green angiography). The criteria used for RAP diagnosis have already been described by our group. 29, 30 For the purposes of this study, we identified and selected consecutive patients with unilateral RAP (Group 1) from the above-mentioned database. The same database was also used to identify consecutive patients with unilateral typical eAMD, to create the control group (Group 2). The following eligibility criteria were considered for patient selection in both groups: 1) any race and either sex, 2) age $50 years, 3) diagnosis of unilateral typical eAMD or RAP at baseline, and 4) fellow eye (study eye) without any signs of neovascularization at enrollment. Patients with ophthalmologic comorbidities (other than agerelated maculopathy) likely to jeopardize the grading of the color fundus pictures were excluded from the study.
Color Fundus Photograph Grading
The mydriatic CFP of the unaffected fellow eye used for grading were obtained at the time of diagnosis of neovascularization in the non-study eye using a Zeiss FF450 Fundus Camera equipped with a Nikon highresolution camera. All the fundus images were centered at the fovea, with a 30°field of view and a 1,594 · 1,326 pixel resolution (50% of maximum resolution) was used for grading purposes. Grading took place at the Coimbra Ophthalmology Reading Center by two independent graders certified by this institution and was performed using RetmarkerAMD (Retmarker SA, Coimbra, Portugal), a computer-assisted grading software developed according to the guidelines of the International Classification and Grading System for AMD. 31 Both free forms and predefined circles (63, 125, 175, 250, and 500 mm) are available for grading and allow for an accurate quantification of fundus features in digital CFP, including drusen, pigmentary changes, geographic atrophy (GA), or exudative lesions ( Figure 1 ). In addition to a categorical depiction of variables, such as the number (0, 1-9, 0-19, $20) and area occupied by drusen (,1%, ,10%, ,25%, ,50%, $50%), the software allows its quantification as continuous variables, thus reflecting the real (absolute) number and area of drusen. 21 The grading results are readily accessible on screen and can be easily exported as a Microsoft Excel file for further statistical analysis.
Statistical Analysis
Distribution of the several parameters was assessed with Mann-Whitney U tests, and influence of age as a covariate was explored with factorial analyses of variance.
Receiver operating characteristic curves and Cox proportional hazard models were used for determining cutoffs and evaluating conversion risks, respectively. Alpha was defined at 0.05 and all analyses were performed with Stata 12.1 for Windows (StataCorp LP, TX).
Results

Study Population
Seventy-nine fellow eyes of RAP (Group 1, n = 40) and unilateral typical eAMD (Group 2, n = 39) were included. All the included subjects were white. The demographic data of both groups are expressed in Table 1 . Patients included in Group 1 were significantly older than patients included in Group 2 (P , 0.001). In the RAP group, 40% (n = 16) of the fellow eyes developed neovascularization during follow-up (mean ± SD: 33.50 ± 21.10 months). The average time to conversion of the fellow eye was 20.56 ± 10.84 months. The cumulative incidence of neovascularization was 12.5% at 1 year, 29.6% at 2 years, 39.9% at 3 years, and 47.6% at 4 years. In the eAMD group (Group 2), conversion to neovascularization occurred in 48.7% (n = 19) of the fellow eyes, during a followup period of 89.54 ± 25.65 months. The average time to conversion was 53.32 ± 25.65 months. The cumulative incidence of neovascularization was 2.6% at 1 year, 13.1% at 2 years, 21.9% at 3 years, 31.6% at 4 years, 34.9% at 5 years, and 62.4% at 10 years.
Analysis of the Fundoscopic Changes
Considering the purposes of this analysis, we initially performed a comparison between the baseline CFP grading results of the 2 groups ( Table 2 ). The total number and area (square micrometers) of drusen in the central 1,000, 3,000, and 6,000 mm were considerably inferior in the fellow eyes of RAP, with statistically significant differences observed in virtually every location (1,000, 3,000, and 6,000 mm). When considering only the total number and area of soft drusen ($125 mm), there were no statistically significant differences between groups in the central 1,000 mm (P = 0.187 and P = 0.118, respectively) or 3,000 mm (P = 0.124 and Fig. 1 . Real-time grading using RetmarkerAMD (Critical Health SA) in one of the included subjects of the RAP group. A. Calibration is achieved after manually identifying the fovea and establishing the optic disk diameter (blue dot and arrow, respectively).
The P = 0.336, respectively). However, in the central 6,000 mm, the total number of drusen $125 mm was significantly smaller (P = 0.021) in the fellow eyes of RAP, although their area was not (P = 0.078).
Despite the significant age difference between groups, a factorial analysis of variance demonstrated that the difference in drusen number was not influenced by the older age of the patients with RAP. Afterward, to identify potential phenotypic risk factors for conversion, we compared the characteristics of fellow eyes of RAP that developed neovascularization (n = 16) during follow-up, with those that did not (n = 24). This analysis revealed that the first presented a borderline significant (P = 0.053) superior total area of drusen $125 mm in the central 6,000 mm (Figure 2) . A receiver operating characteristic curve analysis was used to find the cutoff value that better predicts the advent of neovascularization. A total area of soft drusen ($125 mm) .510.196 mm 2 was shown to significantly increase the risk of neovascularization with 68.75% sensitivity and 70.83% specificity.
The Cox regression analysis revealed an associated hazard ratio of 4.35 (P = 0.005; 95% confidence interval: 1.56-12.15).
Pigmentary changes (hypopigmentation or hyperpigmentation) were found in 13 fellow eyes of the RAP group (32.5%) and in 8 fellow eyes of Group 2 (20.5%). However, the observed differences did not reach statistical significance, regardless of location (central 1,000, 3,000, or 6,000 mm).
Discussion
In patients with RAP, the presence of small hemorrhages, soft drusen, and pigmentary changes is well documented, 2, 16, [23] [24] [25] [26] [27] but an accurate analysis of the fundoscopic features of the fellow eyes was lacking. Using a precise and easily reproducible methodology, 21, 28 we analyzed and compared fundoscopic changes between two demographically similar populations of fellow eyes of RAP and typical eAMD. Although still not widely spread in clinical and/or research settings, the use of semiautomated image analysis systems represents a convenient and versatile way of grading fundus changes, significantly reducing the time and expense associated with manual grading. 32 We found that the total number and area of drusen were significantly lower in fellow eyes of RAP, in almost every location (central 1,000, 3,000, and 6,000 mm). When considering only drusen $125 mm, the difference between groups reached statistical significance for the total number of drusen in the central 6,000 mm (P = 0.0021), although not for their area (P = 0.078). The significance of these results was emphasized after excluding age as a possible confounding factor. Fujimura et al 8 compared drusen area and characteristics of fundus autofluorescence (FAF) between fellow eyes of Japanese patients with polypoid choroidal vasculopathy (PCV) (n = 95), typical eAMD (n = 64), and RAP (n = 4). Despite having found statistically significant differences between the PCV group and the typical eAMD group, the authors reported that it was not possible to adequately characterize the RAP group, due to the small number of subjects included. Another study in Asians, conducted by Kim et al 24 compared the extent and density of drusen between eyes with RAP (n = 20) and typical eAMD (n = 24). The fellow eyes of these patients were also evaluated whenever bilateral neovascularization was not present. The authors found that the density of drusen in the macular area was significantly higher in fellow eyes of RAP (n = 10) than in fellow eyes of typical eAMD (n = 17). 24 These findings are the exact opposite of ours. Aside from the ethnical differences between populations, the study of Kim et al 24 has several important limitations that may have influenced the disparity of results. First of all, the authors analyzed a small number of fellow eyes and presented nonequivalent groups. Furthermore, the evaluation of drusen extent lacks accuracy, since patients were divided in groups: small extent (,1/3 of the fundus photograph), intermediate extent (1/3-2/3 of the fundus photograph), and large extent (.1/3 of the fundus photograph). Therefore, only a mere estimation of the total area occupied by drusen was determined. Finally, in their study drusen density was evaluated only in the central 3,000 mm, when the International Guidelines for classification and grading of AMD 31 consider the central 6,000 mm. Our sample size along with the clear and precise methodology with which we evaluated the total number and area of drusen adds robustness to our analysis and reinforce the obtained results.
We believe that one possible explanation for the differences we found between drusen characteristics in fellow eyes of RAP and typical eAMD may be the frequent development of GA in eyes with RAP. It was previously thought that GA in RAP was secondary to the treatments used. 33, 34 However, in a recent study using FAF, McBain et al 35 found high rates of GA in RAP, independently of treatment modalities (photodynamic therapy or antiangiogenic agents). This finding may constitute a consequence of the reduced choroidal perfusion and thickness in RAP, which may be associated with the high vasogenic potential observed in these patients. 24, 35, 36 Since baseline evaluation of our patients did not include FAF, a precise determination of possible areas of GA in our population of fellow eyes could not be achieved and this constitutes a limitation of our study.
In our study, we have also looked at possible phenotypic risk factors associated with a higher rate of conversion. We found that a total area of soft drusen ($125 mm) .510.2 mm 2 in the central 6,000 mm was associated with a higher risk of neovascularization (hazard ratio, 4.35; 95% confidence interval [1.56-12.15] ; P = 0.005) in fellow eyes of RAP. Although this result should be interpreted carefully, it constitutes a clinically relevant finding since it might allow identification of patients with a high probability of conversion at the time of neovascularization of the first affected eye, in a fast and easy way. Sawa et al 16 evaluated the correlation between several determinants (age, sex, follow-up time, presence of soft drusen, and presence of reticular pseudodrusen [RPD] ) and the development of RAP in fellow eyes. The authors concluded that a long follow-up and the presence of RPD were associated with conversion. 16 In their analysis, they included soft drusen as a categorical variable (present/not present) and did not calculate its area and number. As previously reported, soft drusen are a common finding in RAP 23, 27 so it is totally justifiable that there was no correlation with conversion when the variable is assessed categorically. Several authors have postulated an association between RPD and advanced forms of AMD. [37] [38] [39] [40] Both Zweifel et al 40 and Hogg et al 37 demonstrated that CFP and red-free are poor means for the detection of RPD, and diagnosis is best achieved using infrared or FAF. Since baseline evaluation of our patients did not include either of these retinal imaging modalities, a quantitative evaluation of RPD could not be attained, thus representing a limitation of our study.
The presence of pigmentary changes has been identified as a risk factor for the development of CNV in patients with typical eAMD. 20, 22, 41 Campa et al 15 identified foci of hyperpigmentation in 29 (78.4%) of the 37 fellow eyes of RAP in their study and suggested that these could constitute an important risk factor for the development of RAP since it was present in 90% of those who developed neovascularization. Although we found foci of hyperpigmentation in 1/3 of patients in the RAP group and in 20% of patients in the eAMD group, the difference between groups was not statistically significant, and we found no correlation with the development of neovascularization for any of the groups.
Aside from its retrospective nature, the main limitations of our study are related to multimodal retinal imaging. Baseline FAF and infrared images were not available, and although grading of CFP can reliably evaluate drusen characteristics and pigmentary changes, this method lacks sensitivity in the determination of GA and RPD. We do believe, however, that these limitations have a minor impact in our results.
In conclusion, by using an innovative, meticulous, and easily reproducible grading methodology, we found that the total number and area of drusen are significantly smaller in fellow eyes of RAP and that a total area of soft drusen ($125 mm) .510,196 mm 2 in the central 6,000 mm is strongly associated with the development of neovascularization.
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